This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on june 25, 2021.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date) g3 (date received by manufacturer) g6 (indication that this is a follow-up report) h2 (follow-up due to additional information and device evaluation) h3 (device evaluated by manufacturer) h4 (device manufacture date) h6 (identification of evaluation codes 10, 11, 3331, 3259, 25) type of investigation: #1:10 - testing of actual/suspected device type of investigation #2: 11 - testing of device from same lot/batch retained by manufacturer type of investigation #3: 3331 - analysis of production records investigation findings: 3259 - improper physical structure investigation conclusions: 25 - cause traced to manufacturing the affected sample was inspected upon receipt to show hazing in the back housing and what appeared to be a piece of magnet in the back housing.The sample was attached to a driver where excessive noise was heard, most likely from the piece of magnet.The pump was then disassembled and confirmed an extra piece of magnet in the back housing.All five magnets were removed and each did not have missing pieces.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|